
Conducted between August 1 and August 7, the survey, second in the city, showed that 29.1 percent of the population in the national capital has now developed antibodies against SARS CoV-2.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3gpuJBN
via
IFTTT
0 comments:
Post a Comment